SCHEMBL4927809

SCHEMBL4927809

CCN(CC)c1ccc2c(C)c(-c3ccc4ccn(C(=O)OC(C)(C)C)c4c3)c(=O)oc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.55
▸ KDM4E B2RXH2 7/20 0.55
▸ HPGD P15428 6/20 0.55
▸ MAPT P10636 5/20 0.55
▸ L3MBTL1 Q9Y468 4/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ EP300 Q09472 1/20 0.53
▸ ATM Q13315 8/20 0.46
▸ HSD17B10 Q99714 6/20 0.46
▸ GLA P06280 5/20 0.46
▸ HTT P42858 5/20 0.46
▸ CASP1 P29466 5/20 0.46
▸ CASP7 P55210 5/20 0.46
▸ LMNA P02545 2/20 0.46
▸ THRB P10828 1/20 0.46
▸ GAA P10253 2/20 0.46
▸ KLK7 P49862 1/20 0.46
▸ TDP1 Q9NUW8 3/20 0.45
▸ MAOB P27338 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929175 0.94 EP300 (0.56) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL3835028 0.76 MAPT (0.43) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL13869309 0.76 ALDH1A1 (0.86) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL13869681 0.75 ALDH1A1 (0.70) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL808511 0.73 ALDH1A1 (0.73) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL4922302 0.73 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL30914647 0.73 ALDH1A1 (0.69) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL13869289 0.73 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL30914646 0.72 ALDH1A1 (0.75) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL14160786 0.72 ALDH1A1 (0.75) ALDH1A1KDM4EHPGDMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT ALDH1A1 181/4885KDM4E 1183/4885HPGD 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback